Table 4.
Comparison of our data with the previous cohorts of IMD patients infected with COVID-19 infection.
| Report (year) | Lampe et al. (2020) | Tummolo et al. (2021) | Tobór-Swietek et al. (2021) | Zubarioglu et al. (2021) | This study 2022 |
|---|---|---|---|---|---|
| No. of centers | Multi-centers | 1 Center | Multi-centers | 1 Center | 1 Center |
| Total no. of surveyed IMD patients | 73 | 272 | NA | NA | 1058 |
| Total no. of COVID-19 positive cases | 24 | 19 | 27 | 22 | 124 |
| Pediatrics | 13 | 9 | 10 | 22 | 56 |
| Adult | 11 | 10 | 17 | 0 | 68 |
| Asymptomatic | 1 (4.2%) | 12 (63%) | 0 (0%) | 2 (9%) | 17 (13.7) |
| Hospitalization | 2 (8.3%) | 1 (5.3%) | 4 (14.8%) | 8 (36.4%) | 22 (17.7%) |
| Death | 0 | 0 | 1 (NPC) | 0 | 3 |
NPC Neimann Pick C.